Analyst Just Declared Lilly the Clear Winner at ADA Conference
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesThe ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
NVIDIA stock investors just received a wave of optimism from analysts who see substantial upside as AI adoption accel...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
As AI reshapes markets, Palantir’s unique software moat could ignite a new chapter in growth. This guide compares Pal...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
A fresh payroll report has spurred renewed doubt about U.S. job data. Wall street, analysts increasingly doubt the ac...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
The AI boom has cooled, but the backbone of AI—data centers and cloud services—remains essential. This guide highligh...
Artificial intelligence is reshaping how companies operate and profit. This article breaks down how AI is fueling ear...
Berkshire Hathaway under Greg Abel signals a sharper eye for AI champions. Could Alphabet be the catalyst, with Nvidi...
Three clear visions for AMD in 2026, from AI-driven demand to capital returns. Learn what could move the stock and ho...